Literature DB >> 16702628

Search for drugs of the combined anti-inflammatory and anti-bacterial properties: 1-methyl-N'-(hydroxymethyl)nicotinamide.

Maciej Adamiec1, Jan Adamus, Ireneusz Ciebiada, Andrzej Denys, Jerzy Gebicki.   

Abstract

It has already been reported that 1-methylnicotinamide (MNA+), a primary metabolite of nicotinamide (vitamin B3), possesses remarkable anti-inflammatory properties [3]. This communication shows that 1-methyl-N'-(hydroxymethyl)nicotinamide (MNAF+ can be regarded as MNA+ precursor able to release simultaneously formaldehyde. Therefore, MNAF+ can be viewed as a candidate for drug with the combined anti-inflammatory and anti-bacterial properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702628

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  2 in total

1.  Effects of N1-methylnicotinamide on oxidative and glycooxidative stress markers in rats with streptozotocin-induced diabetes mellitus.

Authors:  Zuzana Országhová; Ol'ga Uličná; Anna Liptáková; Ingrid Zitňanová; Jana Muchová; Cezary Watala; Zdeňka Duračková
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

2.  1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages.

Authors:  Rafał Biedroń; Marta Ciszek; Marianna Tokarczyk; Małgorzata Bobek; Maria Kurnyta; Ewa M Słominska; Ryszard T Smoleński; Janusz Marcinkiewicz
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-03-31       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.